1. Home
  2. CCB vs WVE Comparison

CCB vs WVE Comparison

Compare CCB & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coastal Financial Corporation

CCB

Coastal Financial Corporation

HOLD

Current Price

$116.73

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$17.82

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCB
WVE
Founded
1997
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
CCB
WVE
Price
$116.73
$17.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
16
Target Price
$117.50
$29.94
AVG Volume (30 Days)
110.6K
13.7M
Earning Date
01-27-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
6.19
N/A
EPS
3.17
N/A
Revenue
$343,667,000.00
$109,230,000.00
Revenue This Year
$85.02
N/A
Revenue Next Year
$17.38
$16.00
P/E Ratio
$36.93
N/A
Revenue Growth
26.18
103.75
52 Week Low
$76.11
$5.28
52 Week High
$120.05
$21.73

Technical Indicators

Market Signals
Indicator
CCB
WVE
Relative Strength Index (RSI) 59.28 65.81
Support Level $112.57 $15.23
Resistance Level $120.05 $18.50
Average True Range (ATR) 3.44 2.08
MACD 0.01 0.08
Stochastic Oscillator 70.82 56.27

Price Performance

Historical Comparison
CCB
WVE

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: